Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Vaccine

• Publication date

  2008-01-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2007.10.064PMID 18054414PMCID PMC2253722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase 1 Study of Two Merozoite Surface Protein 1 (MSP142) Vaccines for Plasmodium falciparum Malaria

  2007cited by this paper
• Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria

  2005cited by this paper
• Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.

  2005cited by this paper
• Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials.

  2003influential reference
• Large-scale purification and characterization of malaria vaccine candidate antigen Pvs25H for use in clinical trials.

  2002influential reference
• In Vitro Studies with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response

  2002cited by this paper
• Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay

  1994cited by this paper
• Factors affecting the fine specificity and sensitivity of serum antiganglioside antibodies in ELISA.

  1994cited by this paper
• Comparison of an ELISA system for the quantification of hepatitis B antibody with an automated and a semi-automated system.

  1993cited by this paper
• Increased coating efficiency of antigens and preservation of original antigenic structure after coating in ELISA.

  1989cited by this paper
• Enhanced ELISA: how to measure less than 10 picograms of a specific protein (immunoglobulin) in less than 8 hours

  1988cited by this paper
• Indirect enzyme linked immunosorbent assay (ELISA): practical aspects of standardization and quality control.

  1981cited by this paper
• Enzyme immunoassays with special reference to ELISA techniques.

  1978cited by this paper
• Quantitative enzyme immunoassay (ELISA) in microbiology.

  1977cited by this paper
• The enzyme-linked immunosorbent assay (ELISA).

  1976influential reference
• Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

  1972cited by this paper
• Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

  1971cited by this paper
• Immunoassay using antigen—enzyme conjugates

  1971cited by this paper

• Seroprevalence of antibodies to Plasmodium falciparum transmission-blocking target proteins Pfs230D1M and Pfs48/45 in Tanzanian populations of diverse malaria transmission intensity

  2025cites this paper
• Validation of a multiplexed immunoassay for immunological analysis of pre erythrocytic malaria vaccines

  2025cites this paper
• 50-Fold Adjuvant and 20-Fold Antigen Vaccine Dose Sparing from Nanoliposome Display of a Stabilized Malarial Protein Antigen.

  2025cites this paper
• Development of ELISA Assay for Antibody Detection in Cancer Vaccine Research.

  2025cites this paper
• Rabies glycoprotein engineering for improved stability and expression

  2025cites this paper
• iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA

  2025cites this paper
• Unraveling the immunogenic landscape: A quest for B-cell linear epitopes in the African swine fever virus H339R protein.

  2025cites this paper
• Development of immunogold test strips for chilli veinal mottle virus detection using monoclonal antibodies against the CP

  2025cites this paper
• Priming or Boosting P. falciparum Transmission Blocking Responses with Recombinant Vaccines or Gametocyte Extract.

  2025cites this paper
• Beyond the limits of conventional 'endpoint' ELISA and rescuing the signal with lag k-ELISA.

  2025cites this paper
• Plasmodium falciparum expresses fewer var genes at lower levels during asymptomatic dry season infections than clinical malaria cases

  2025cites this paper
• Evaluation of transmission-blocking potential of PvPSOP25 using transgenic murine malaria parasite and clinical isolates

  2024cites this paper
• Humoral Immunity Profiling to Pandemic and Bat‐Derived Coronavirus Variants: A Geographical Comparison

  2024cites this paper
• Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

  2024cites this paper
• A reverse vaccinology approach identified novel recombinant tick proteins with protective efficacy against Rhipicephalus microplus infestation.

  2024cites this paper
• Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies

  2024cites this paper
• Antigen specificity affects analysis of natural antibodies

  2024cites this paper
• Immature dendritic cell-targeting mRNA vaccine expressing PfCSP enhances protective immune responses against Plasmodium liver infection

  2024cites this paper
• Autoantibodies inhibit Plasmodium falciparum growth and are associated with protection from clinical malaria.

  2024cites this paper
• Interaction of Bacteriophages with the Immune System: Induction of Bacteriophage-Specific Antibodies.

  2024cites this paper
• Unravelling heterogeneous malaria transmission dynamics in the Peruvian Amazon: insights from a cross-sectional survey

  2024cites this paper
• Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens

  2024cites this paper
• Evaluation of transmission-blocking potential of Pv22 using clinical Plasmodium vivax infections and transgenic Plasmodium berghei.

  2023cites this paper
• Influence of Live Attenuated Salmonella Vaccines on Cecal Microbiome Composition and Microbiota Abundances in Young Broiler Chickens

  2023cites this paper
• A dual-antigen malaria vaccine targeting Pb22 and Pbg37 was able to induce robust transmission-blocking activity

  2023cites this paper
• Superior antibody immunogenicity of a RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults

  2023cites this paper
• Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.

  2023cites this paper
• Analyses of vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens

  2023cites this paper
• Structure guided mimicry of an essential P. falciparum receptor-ligand complex enhances cross neutralizing antibodies

  2023cites this paper
• Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA

  2023cites this paper
• Functional characterization of a conserved membrane protein, Pbs54, involved in gamete fertilization in Plasmodium berghei.

  2023cites this paper
• Analyzing Electrochemical Sensing Fundamentals for Health Applications

  2023cites this paper
• Structure guided mimicry of an essential P. falciparum receptor-ligand complex enhances cross neutralizing antibodies

  2023cites this paper
• Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA

  2022cites this paper
• Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages

  2022cites this paper
• Understanding the role of serological and clinical data on assessing the dynamic of malaria transmission: a case study of Bagamoyo district, Tanzania

  2022cites this paper
• Emerging ELISA Derived Technologies for in vitro Diagnostics

  2022cites this paper
• Elucidating functional epitopes within the N-terminal region of malaria transmission blocking vaccine antigen Pfs230

  2022cites this paper
• Elucidating functional epitopes within the N-terminal region of malaria transmission blocking vaccine antigen Pfs230

  2022cites this paper
• Seroprevelance and Antibiotic Resistance of Salmonella spp. Isolated From Pigeons and Their Environment in Nineveh Governorate

  2022cites this paper
• Bbvac: A Live Vaccine Candidate That Provides Long-Lasting Anamnestic and Th17-Mediated Immunity against the Three Classical Bordetella spp.

  2022cites this paper
• Complementary measurement of nontyphoidal Salmonella-specific IgG and IgA antibodies in oral fluid and serum

  2022cites this paper
• Characterization of PSOP26 as an ookinete surface antigen with improved transmission-blocking activity when fused with PSOP25

  2022cites this paper
• Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses

  2022cites this paper
• Development and Qualification of an Antigen Integrity Assay for a Plasmodium falciparum Malaria Transmission Blocking Vaccine Candidate, Pfs230

  2022cites this paper
• Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine

  2022cites this paper
• Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings

  2022cites this paper
• Half-life of Ingested Antibodies in Anopheles Stephensi Mosquito Is Less Than 10 Hours

  2021cites this paper
• Immunogenicity of full-length P. vivax rPvs48/45 protein formulations in BALB/c mice.

  2021cites this paper
• Development and characterization of a quantitative ELISA to detect anti-SARS-CoV-2 spike antibodies

  2021cites this paper
• Identification of anti-horn fly vaccine antigen candidates using a reverse vaccinology approach

  2021cites this paper
• Poor CD4+ T Cell Immunogenicity Limits Humoral Immunity to P. falciparum Transmission-Blocking Candidate Pfs25 in Humans

  2021cites this paper
• Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies

  2021cites this paper
• Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post–COVID-19 Convalescent Samples

  2021cites this paper
• Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors

  2021cites this paper
• A guide to investigating immune responses elicited by whole‐sporozoite pre‐erythrocytic vaccines against malaria

  2021cites this paper
• Galectins from Onchocerca ochengi and O. volvulus and their immune recognition by Wistar rats, Gudali zebu cattle and human hosts

  2021cites this paper
• Immune Response to Therapeutic Staphylococcal Bacteriophages in Mammals: Kinetics of Induction, Immunogenic Structural Proteins, Natural and Induced Antibodies

  2021cites this paper
• Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax rPvs48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems

  2021cites this paper
• Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples

  2021cites this paper
• CD4+ T Follicular Helper Cells in Human Tonsils and Blood Are Clonally Convergent but Divergent from Non-Tfh CD4+ Cells

  2020cites this paper
• Immunoreactivity and neutralization study of Chinese Bungarus multicinctus antivenin and lab-prepared anti-bungarotoxin antisera towards purified bungarotoxins and snake venoms

  2020cites this paper
• Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations

  2020cites this paper
• Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment

  2020cites this paper
• Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate.

  2020cites this paper
• Lyophilized, antigen-bound liposomes with reduced MPLA and enhanced thermostability.

  2020cites this paper
• A conserved malaria parasite antigen Pb22 plays a critical role in male gametogenesis in Plasmodium berghei

  2020cites this paper
• A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system

  2020cites this paper
• Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose

  2020cites this paper
• Chapter 2 General Overviews on Applications of ELISA

  2019cites this paper
• ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum.

  2019cites this paper
• A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria

  2019cites this paper
• Utility of Centrifugation-Controlled Convective (C3) Flow for Rapid On-chip ELISA

  2019cites this paper
• The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate

  2019cites this paper
• Induction of Phage-Specific Antibodies by Two Therapeutic Staphylococcal Bacteriophages Administered per os

  2019cites this paper
• CD4+ T follicular helper (Tfh) cells in human tonsil and blood are clonally convergent, but divergent from non-Tfh CD4+ cells

  2019cites this paper
• Humoral Immune Response to Phage-Based Therapeutics

  2019cites this paper
• A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates

  2019cites this paper
• Techniques Related to Disease Diagnosis and Therapeutics

  2019cites this paper
• Functional Comparison of Blood-Stage Plasmodium falciparum Malaria Vaccine Candidate Antigens

  2019cites this paper
• The Expression Of Recombinant Plasmodium Falciparum Sexual-Stage Proteins And Assessment Of Naturally Acquired Transmission-Blocking Immunity

  2019cites this paper
• Onchocerca - infected cattle produce strong antibody responses to excretory-secretory proteins released from adult male Onchocerca ochengi worms

  2018cites this paper
• Interaction of Bacteriophages with the Immune System: Induction of Bacteriophage-Specific Antibodies.

  2018cites this paper
• A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model.

  2018cites this paper
• Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever.

  2018cites this paper
• General Overviews on Applications of ELISA

  2018cites this paper
• Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines

  2018cites this paper
• IgG subclass responses to excreted-secreted antigens of Plasmodium falciparum in a low-transmission malaria area of the Peruvian Amazon

  2018cites this paper
• A potent neutralizing epitope of limited variability in the head domain of haemagglutinin as a novel influenza vaccine target

  2018cites this paper
• Combination of RTS,S and Pfs25-IMX313 Induces a Functional Antibody Response Against Malaria Infection and Transmission in Mice

  2018cites this paper
• Optimization of a magnetic bead-based assay (MAGPIX®-Luminex) for immune surveillance of exposure to malaria using multiple Plasmodium antigens and sera from different endemic settings

  2018cites this paper
• Poly(I:C) adjuvant strongly enhances parasite-inhibitory antibodies and Th1 response against Plasmodium falciparum merozoite surface protein-1 (42-kDa fragment) in BALB/c mice

  2018cites this paper
• A Malaria Vaccine Adjuvant Based on Recombinant Antigen Binding to Liposomes

  2018cites this paper
• A STUDY ON THE IMPACT OF REPEATED FREEZE-THAW CYCLES ON THE SERUM CYTOKINE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)

  2018cites this paper
• Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential

  2018cites this paper
• Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells

  2018cites this paper
• N-Terminal Pfs230 Domain Produced in Baculovirus as a Biological Active Transmission-Blocking Vaccine Candidate

  2017cites this paper
• Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge

  2017cites this paper
• Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal ‘C-tag’

  2017cites this paper
• Immune Cross-Opsonization Withinemm Clusters Following Group AStreptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity

  2017cites this paper